Buffett plows money into GSK, Sanofi

Where Warren Buffett goes, others follow--and that's why anyone holding GlaxoSmithKline or Sanofi-Aventis options is smiling today. The billionaire investor's holding company told the Securities and Exchange Commission that it now owns 1.5 million of GSK's American Depository Receipts, valued at $76.1 million, and 3.6 million Sanofi ADRs, worth $162.5 million. GSK is already up 1.5 percent on the news.

- read the report from Forbes
- see more at Interactive Investor

Suggested Articles

It’s final: England won’t be covering AZ’s quick-selling Tagrisso in previously untreated non-small cell lung cancer patients with EGFR mutatations.

Top J&J meds have managed to hang onto market share in the face of new generics and biosims, but the drugmaker expects the pain to continue in 2020.

Lonza’s search for a new CEO is expected to be wrapped up this year as the CDMO homes in on a list of veterans from outside the company.